Rapid progress in the ability to manipulate the human body at the cellular level has opened up a huge field of opportunity for businesses with cutting edge knowledge and skill.

The Herndon Biotechnology Fund has a growing portfolio of LEADING Biotech companies, that discover cures and transform lives. The investments Herndon Biotech fund has made in this sector will enable the companies to utilise specialised chemistry and biology to create novel treatments for human diseases.

Herndon is actively looking to partner with companies and innovators seeking develop highly selective therapeutics to target human disease. Herndon Biotech Fund investment approach will lead to a firmly believe that this approach will surpass the current pharmacological regime. Herndon is determined to be a part of this revolution.